Executive Lookbook

M.D., University of Vermont College of Medicine

B.S., Worcester Polytechnic Institute 

• Research Scholar, Howard Hughes Medical Institute/National Institutes of Health Research Scholars Program, Laboratory of Pathology, National Cancer Institute, National Institutes of Health
• Attending Physician,  Pediatric Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health
• Investigator, Tenure-Track: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

• NIH Merit Award, Individual, for developing DCEG’s Genetic Epidemiology of Telomere Maintenance in Cancer Etiology research program, and discovering the TINF2 dyskeratosis congenita susceptibility gene
• Elected to Society for Pediatric Research
• Elected to American Society for Clinical Investigation
• NCI Outstanding Mentor Award, National Cancer Institute, NIH
• NCI Director’s Award of Merit for COVID-19 Pandemic Infrastructure and Administration Leadership
• Robert H. Goddard Alumni Award for Outstanding Professional Achievement, Worcester Polytechnic Institute

• M.D., Ph.D., Loma Linda University

• Deputy Chief, Laboratory of Tumor Immunology and Biology
• CCR, NCI Chief, Genitourinary Malignancies Branch,
• CCR, NCI Director, Medical Oncology Service, CCR, NCI  

• Known for expertise in immunotherapy, having designed and conducted >100 clinical trials from first-in-human / first-in-class therapies to randomized controlled registration endpoint studies.
• 2010 Presidential Early Career Award for Scientists and Engineers, the highest award bestowed by the US President on investigators early in their careers.
• 2018 Hubert H. Humphrey Award for Service to America for contributing to the health, safety, and well-being of the nation by helping to get FDA approval for avelumab for Merkel cell carcinoma and urothelial carcinoma.
• Multiple other awards including 10 NCI or NIH Director’s Awards. 

• B.S., Business Administration, Shepherd University

• Deputy Executive Officer, NCI

• Over 23 years of administrative management and business experience at NIH  

• MPH - NJ School of Public Health 
• BA- University of Delaware

• Deputy EO, NCI 
• Special Assistant to the Director, NCI 
• Chief, Communications Strategy and Program Branch, Office of Communications , NCI

• Accomplished public administrator with over 25 years of experience providing executive leadership, including scientific program and policy development, issues management, and management analysis.
• Collaborative and inclusive approach toward building coalitions, advancing diversity, leading change, and implementing process improvements to support organizational missions. 
• Highly skilled in communications, strategic planning, stakeholder relations, program analysis, resource management, and problem-solving activities. 
• Broad knowledge and experience in contracts administration, management of administrative services, budget, grants administration, and facilities management.

• Ophthalmology residency and fellowship, Johns Hopkins Wilmer Eye Institute.
• MD, Harvard Medical School.
• MA (biomedical informatics), Columbia University.
• BS, Stanford University.

• Knowles Professor of Ophthalmology & Medical Informatics and Clinical Epidemiology, Oregon Health & Science University (OHSU).
• Associate Director, OHSU Casey Eye Institute.

• Published over 200 papers involving applications of information technology to vision science.
• Associate Editor or Editorial Board member of 5 journals, including Ophthalmology and Journal of the American Medical Informatics Association.
• Numerous research, teaching, and clinical awards.

• Ph.D. Rensselaer Polytechnic Institute
• M.S. Rensselaer Institute; B.S.
• St. Joseph's College

• Associate Director for Science Strategic Initiatives and Programs NEI
• Director of Grants and Awards, Foundation Fighting Blindness

• Designed and implemented the National Ophthalmic Disease Genotyping and Phenotyping Network or eyeGENE®, a pioneering public private partnership in genomic medicine that ties advances in ophthalmic disease gene identification and disease phenotype to clinical care.
• Holds a patent for Hydroxylamine Compositions for the Prevention or Retardation of Cataracts.
• Member of several professional societies, including The Association for Research in Vision and Ophthalmology.

•  Ph.D., University of Michigan

• Ph.D., (Immunology) University of Bristol, UK
• MRCOphth (Ophthalmology), Royal College of Ophthalmologists, UK
• MRCS (Surgery), Royal College of Surgeons of England, UK
• M.D. (BM.BS., Medicine & Surgery), University of Nottingham, UK
• B.Med.Sci (Medical Sciences), University of Nottingham, UK

• Clinical Director, Research & Development, Moorfields Eye Hospital NHS Foundation Trust, UK
• Director, Uveitis & Scleritis Service, Moorfields Eye Hospital NHS Foundation Trust, UK
• Professor of Translational Immunology, University College London Institute of Ophthalmology, UK

• Numerous peer-reviewed publications in the fields of ophthalmology and immunology.
• Substantial track record of institutional and personal grant income.
• Major contributions to research on immunotherapies for inflammatory eye diseases.
• Prior advisor to industry and nonprofits.
• Organizational leadership spanning the transformation of clinical services, delivery of research programs in experimental medicine and clinical trials, academic and hospital partnerships, research commercialization and data science.

B.S., York College of Pennsylvania

Deputy Executive Officer, NEI

• MD, Harvard Medical School
• BA, Princeton University

• Previously served as the founding director of the Cardiovascular Research Institute at the Morehouse School of Medicine in Atlanta, GA. During his tenure, the Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations.
• Received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular disease.
• Elected to the National Academies of Sciences (formerly Institute of Medicine) and selected as a Pew Foundation Biomedical Scholar.

• B.S. Georgetown University
• M.D. Georgetown University

• Appointed as Assistant United States Surgeon General Rear Admiral (2^nd star-Upper Half) Commissioned Corps of the United States Public Health Service, Jan 2020 – present.
• Appointed Rear Admiral (lower Half) United States Public Health Service, Nov 2015 – present.
• Clinical Director, NHLBI, Feb 2013 – present.
• Deputy Clinical Director, NHLBI, Feb 2011 – Jan 2012.
• Tenured at NIH-Chief, Lab of Transplantation Immunotherapy, NHLBI, Jan 2007 – present.
• NHLBI Tenure Track Investigator-Tumor Immunology, July 1999 – 2007.   

• Senior investigator at the NHLBI for more than 25 years conducting first-in-human research in the field of experimental allogeneic hematopoietic stem cell transplantation and tumor immunotherapy. First investigator to establish the existence of a graft-vs-solid tumor effect in metastatic kidney cancer. This pioneering research led to the discovery of human endogenous retroviruses being targets for immunotherapy in kidney cancer.
• Has served for more than 10 years as NHLBI's Clinical Director during which time he completely revamped NHLBI’s clinical research infrastructure assisting the ability of DIR researchers to conduct high-risk translational research.
• Has served in multiple major leadership roles in Corps deployments including serving as the Chief Medical Officer for the Ebola Crisis Response in 2014/2015 in Liberia, West Africa, commanding the strike team sent to Tokyo Japan in February 2020 to rescue Americans on the Diamond Princess infected with COVID-19, Commanding Operation Artemis, the largest Unaccompanied Children mission in our nation’s history, and most recently serving as the Interim Director of Commissioned Corps Headquarters, where he directed day-to-day operations for more than 6,000 active duty U.S. Public Health Service Officers. 
• Rear Admiral Childs is one of the most highly decorated active-duty officers in the U.S. Public Health Service, having received the Distinguished Service Medal with Valor, the Meritorious Service Medal, the Assistant Secretary of Health’s Exceptional Service Medal, and the Humanitarian Service and Global Health Award.
• Was elected to the American Society of Clinical Investigation (ASCI) and is the recipient of numerous awards, including the NIH Director’s Scientific Medal Award, the NIH Clinical Center’s Distinguished Clinical Teacher Award, the American College of Physicians (ACP) National Award for Outstanding Work in Science as Related to Medicine.

• M.D. University of Göttingen, Germany
• Ph.D. University of Göttingen, Germany
• M.B.A. New York University- Stern

• Deputy Clinical Director, NHLBI, 2019-2024
• Medical Officer, NHLBI, 2006-present

• Has served for more than 10 years in multiple leadership roles within the office of the NHLBI Clinical Director and was instrumental in revamping its clinical research infrastructure. 

• B.A in American Studies, University of Maryland. 
• M.S. in Electronic Commerce, University of Maryland. 

• Ariel joined the federal service in 2005, and has served in many roles across NHLBI including Administrative Officer and Supervisory Section Chief within the Division of Intramural Management, Director of Ethics, Director of Executive Services, and the NHLBI Deputy Executive Officer. Prior to his arrival at NIH, Ariel served as a Program Advisor within the Grants Resource Center at the American Association of State Colleges and Universities.

• Ariel has played a key role in enhancing business operations through his involvement in major implementation initiatives. His contributions have been instrumental in the successful deployment of critical systems such as POTS, TRAC, and the Intranet, driving operational efficiency and organizational excellence.

• M.D., Ph.D. Washington University, St. Louis
• B.S., University of Wisconsin, Madison

• NHGRI Scientific Director (2002-2009)
• Founding Director, NIH Intramural Sequencing Center (1997-2009)

• Co-authored over 350 scientific publications

• J.D., The Ohio State University, Moritz College of Law, Columbus OH
• B.A., Michigan State University, James Madison College, East Lansing MI

• 2003-present - Associate Investigator and Head of the Health Disparities Unit, Social and Behavioral Research Branch, Division of Intramural Research, NHGRI
• 2021-present - Acting Director Training Diversity and Health Equity Office, NHGRI  
• 2012-2021 - Senior Advisor to the Director on Genomics and Health Disparities, NHGRI
• 2003-2015 - Founding Branch Chief, Education and Community Involvement Branch, NHGRI
• 2001-2003 - Associate Professor, College of Human Medicine, Michigan State University

• Leader within health disparities research
• Author of >100 articles and book chapters
• Mentored many trainees from diverse backgrounds